An interventional study of inguinal ligament mobilization or talonavicular joint mobilization or both inguinal and talonavicular joint mobilizations or conventional physical therapy exercises in Patellofemoral Pain Syndrome, sponsored by Cairo University. Enrolling by invitation at 1 site in Egypt. Open to participants aged 18 Years to 40 Years. Per ClinicalTrials.gov, last updated 2026-07-29.
Sponsored by Cairo University · Not applicable, Interventional, and Treatment
Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →
Among 30 studies in Patellofemoral Pain Syndrome by Cairo University — 12 open to participants now, 13 under way, none of them phase 3. Patellofemoral Pain Syndrome · Cairo University.
Among the 30 studies in Patellofemoral Pain Syndrome by Cairo University, this one is the 2nd largest by planned enrollment of the 22 interventional ones that give a count, is one of 10 that started in 2026, is one of 22 with no phase, reaches primary completion later than 6 of the 12 other live ones, and was the 21st registered.
297 studies on the registry are indexed under Patellofemoral Pain Syndrome; 73 are open to participants now.
Browse Patellofemoral Pain Syndrome studies →12 of the 30 studies in Patellofemoral Pain Syndrome by Cairo University are open now, in 3 countries. Recruiting first, the newest first:
Cairo University · Sites in Lebanon
Ages 18–50
Cairo University · Sites in Egypt
Ages 18–30
Cairo University · Sites in Egypt
Ages 18–35
Cairo University · Sites in Egypt
Ages 18–35
Cairo University · Sites in Egypt
Ages 18–35
By country, each count listing its studies:
Of the 44 Patellofemoral Pain Syndrome studies recruiting now, 3 (7%) set no upper age limit and 40 (91%) stop at 75 or younger; 6 take children under 18; 12 take healthy volunteers.
This study: 18 Years to 40 Years · all sexes · no healthy volunteers.
The full table on the hub →This tab as a report to print or save as PDF → With an account.
30 studies; the count open now beside each. This study's row is marked.
First in 2018; this study’s year is marked. 10 started in 2026.
This study's planned enrollment of 80 is above the median of 45 across 244 interventional studies indexed under Patellofemoral Pain Syndrome.
Median enrollment 58 across the 22 interventional studies, 53 across the 8 observational. Of the 12 that completed or were terminated, 0 (0%) have results posted.
This tab as a report to print or save as PDF → With an account.
Cairo University is the lead sponsor of 4,967 studies on the registry; 1,474 are open to participants now.
Of its 37 completed or terminated interventional studies of FDA-regulated products, 5 (14%) have results posted.
2 of the studies in Patellofemoral Pain Syndrome by Cairo University that are under way reach primary completion within a year, 0 of them phase 3. Phase 3 first, then by date:
| Study | Primary completion |
|---|---|
| NCT07664566Cairo UniversityCore Stability Exercises Versus Proprioceptive Training on Pain and Function in Patients With Patellofemoral Pain Syndrome | 2027-03-20 |
| NCT07806929Cairo UniversityComparison Between Foot Segment Mulligan Mobilization and Ilium Mulligan Mobilization in Treatment Patellofemoral Pain Patients With Flatfeet: a Randomized Controlled Comparative Study | 2027-11-01 |
Add all 2 to your calendar (.ics) → With an account.
Among the 30 studies in Patellofemoral Pain Syndrome by Cairo University, from their registry updates:
Nothing recorded among them since 2026-09-25.
This tab as a report to print or save as PDF → With an account.
This study will be conducted to:
Patellofemoral pain syndrome is pain around and under the patella (kneecap). The condition is also known as runner's or jumper's knee and affects both kids and adults. It can also occur in one or both knees . Patellofemoral pain syndrome (PFPS) is one of the most common orthopedic knee afflictions among both adults and adolescents. This syndrome, constitutes 5% of all injuries and 25% of knee injuries. It is characterized by pain in the back of the knee cap that comes in contact with the femur , and it is usually aggravated by walking stairs, deep squatting, kneeling, prolonged sitting, and standing up from sitting.
The treatment of PFPS varies from medication and up to different rehabilitation approaches, including balance and proprioceptive exercises to regain normal activities of daily level and optimizing function. Also, the rehabilitation of PFPS includes conservative treatments of physical therapy for symptoms such as muscle strengthening exercises (quadriceps femoris and hip abductors), flexibility exercises (rectus femoris, hamstring, gastrocnemius, hip flexors), foot orthoses to reduce pronated foot, patellofemoral joint taping, braces, and non-steroidal anti-inflammatory drugs (NSAIDs).
Some studies have reported a pronated foot as an intrinsic risk factor for PFPS, suggesting that it may be a solution to the underlying problem. Abnormal motion of the talonavicular joint due to navicular drop or drift in the pronated foot is an indicator of the overall function of the foot. Similarly, studies have shown a correlation between the pronated foot and PFPS. A pronated foot is defined as the flattening or loss of the medial longitudinal arch (MLA). Changes in the lower extremity alignment can cause calcaneal eversion, tibia internal rotation, valgus knee, and femur internal rotation in the normal structure, altering the angle of muscle contraction of the quadriceps femoris, causing the patella to track in the lateral direction, resulting in lower extremity dysfunction.
Foot interventions in patients with patellofemoral pain have shown significant effectiveness of the talonavicular joint mobilization (TJM) to maintain foot posture and to control hypermobility of the talonavicular joint of the pronated foot which will cause changes in PFPS pain, lower extremity function, valgus knee, foot posture. Foot core strengthening: relevance in injury prevention and rehabilitation for runners.
One potential intervention that has gained attention is inguinal ligament mobilization (ILM), a manual therapy technique designed to address pelvic and hip alignment that could indirectly affect knee mechanics. Inguinal ligament mobilization is thought to improve the mobility and function of the surrounding structures, potentially alleviating PFPS symptoms.
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Diagnosis of PFPS, based on clinical and radiographic criteria (no other knee pathologies) referred by orthopedic physicians.
Exclusion Criteria:
Chronic pain conditions unrelated to PFPS.
Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Weight in kilograms divided by height in metres squared. Example: 70 kg and 1.75 m gives 70 ÷ (1.75 × 1.75) ≈ 22.9.
What counts as overweight or obesity differs between countries (some use lower cut-offs), so go by the range the study states.
Anti-inflammatory medicines such as prednisone, prednisolone and dexamethasone — not the anabolic steroids used for muscle.
Studies differ in what they allow: check which steroid medicines, routes (tablets, injections, creams, inhalers, eye drops) and doses this study accepts.
BMI (body mass index)
Weight in kilograms divided by height in metres squared. Example: 70 kg and 1.75 m gives 70 ÷ (1.75 × 1.75) ≈ 22.9.
What counts as overweight or obesity differs between countries (some use lower cut-offs), so go by the range the study states.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Corticosteroids (steroids)
Anti-inflammatory medicines such as prednisone, prednisolone and dexamethasone — not the anabolic steroids used for muscle.
Studies differ in what they allow: check which steroid medicines, routes (tablets, injections, creams, inhalers, eye drops) and doses this study accepts.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Group A: An intervention group (n = 20) receiving inguinal ligament mobilization (ILM) with conventional physical therapy exercises.
Other: inguinal ligament mobilization or talonavicular joint mobilization or both inguinal and talonavicular joint mobilizations or conventional physical therapy exercises
Group B: An intervention group (n = 20) receiving talonavicular joint mobilization (TJM) with conventional physical therapy exercises.
Other: inguinal ligament mobilization or talonavicular joint mobilization or both inguinal and talonavicular joint mobilizations or conventional physical therapy exercises
Group C: An intervention group (n = 20) receiving combined inguinal ligament mobilization, talonavicular joint mobilization and conventional physical therapy exercises.
Other: inguinal ligament mobilization or talonavicular joint mobilization or both inguinal and talonavicular joint mobilizations or conventional physical therapy exercises
Group D: A control group (n = 20) receiving conventional physical therapy exercises only
Other: inguinal ligament mobilization or talonavicular joint mobilization or both inguinal and talonavicular joint mobilizations or conventional physical therapy exercises
2 sessions per week for total 4 weeks of treatment
pain intensity
1.Effect of adding inguinal ligament mobilization to talonavicular joint mobilization on pain intensity in subjects with PFPS. and it is measured by Visual Analogue Scale (100 mm (10-cm) straight line with descriptive anchors at each extreme to measure pain intensity)
Time frame: Inguinal Ligament Mobilization will last 20 minutes, with 2 sessions per week over 4 weeks.Mobilization of talonavicular Two sets of 5 minutes totally for 4 weeks for two sessions per week.conventional physical therapy 2 sessions per week for 4 weeks.
pain threshold
2.Effect of adding inguinal ligament mobilization to talonavicular joint mobilization on pain threshold in subjects with PFPS. and it is measured by pressure algometer (a handheld diagnostic device used to objectively quantify pain sensitivity by measuring the exact force at which a patient begins to feel pain).
Time frame: Inguinal Ligament Mobilization will last 20 minutes, with 2 sessions per week over 4 weeks.Mobilization of talonavicular Two sets of 5 minutes totally for 4 weeks for two sessions per week.conventional physical therapy 2 sessions per week for 4 weeks.
knee function
3.Effect of adding inguinal ligament mobilization to talonavicular joint mobilization on knee function in subjects with PFPS. and it is measured by Kujala Patelofemoral Pain Questionnaire (in score from 13-question survey used to measure knee pain, function, and symptoms related to the kneecap. It scores from 0 to 100 points, where 100 means no pain or disability).
Time frame: Inguinal Ligament Mobilization will last 20 minutes, with 2 sessions per week over 4 weeks.Mobilization of talonavicular Two sets of 5 minutes totally for 4 weeks for two sessions per week.conventional physical therapy 2 sessions per week for 4 weeks.
Q angle
4.Effect of adding inguinal ligament mobilization to talonavicular joint mobilization on Q angle in subjects with PFPS. and it is measured by Goniometer (in angles)
Time frame: Inguinal Ligament Mobilization will last 20 minutes, with 2 sessions per week over 4 weeks.Mobilization of talonavicular Two sets of 5 minutes totally for 4 weeks for two sessions per week.conventional physical therapy 2 sessions per week for 4 weeks.
Plan to share: No
Started Mar 2026 (actual). Primary completion is estimated for Aug 2026, 5 months after the start.
Of 153 non-industry interventional studies with no phase under Patellofemoral Pain Syndrome, half reached primary completion within 11 months of starting (the median), counting those still running; a quarter within 4 and three quarters within 21. This study's planned 5 months is below that.
Counting every sponsor, half of 157 studies reached it within 11 months; a quarter within 4 and three quarters within 21.
How these figures are worked out, and which studies are left out of them.
Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.
No contact was published for this record. The registry link below has the sponsor’s details.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Patellofemoral Pain Syndrome →